Back
Opus Genetics Vs. Syros Pharmaceuticals Industry Stock Comparison
Sell
37
IRD
Opus Genetics
Last Price:
1.07
Seasonality Move:
3.61%
Sell
33
SYRS
Syros Pharmaceuticals
Last Price:
0.27
Seasonality Move:
17.91%
Sell
37
Opus Genetics (IRD)
is a Sell
Is Opus Genetics a Buy, Sell or Hold?
- The current Opus Genetics [IRD] share price is $1.09. The Score for IRD is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- IRD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Syros Pharmaceuticals (SYRS)
is a Sell
Is Syros Pharmaceuticals a Buy, Sell or Hold?
- The current Syros Pharmaceuticals [SYRS] share price is $0.36. The Score for SYRS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- SYRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IRD Stock Price Chart
What is Opus Genetics's stock price today?
-
The Opus Genetics share price today is $1.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IRD is experiencing slight selling pressure.
SYRS Stock Price Chart
What is Syros Pharmaceuticals's stock price today?
-
The Syros Pharmaceuticals share price today is $0.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRS is experiencing selling pressure, which indicates risk of future bearish movement.
IRD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 38.95 | Sell |
Chaikin Money Flow: | -114040 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.13 - 1.29) | Sell |
Bollinger Bands (100): | (1.16 - 1.72) | Sell |
SYRS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 28.2 | Sell |
Chaikin Money Flow: | -25163664 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.72 - 2.72) | Sell |
Bollinger Bands (100): | (1.39 - 5.03) | Sell |
IRD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.14 | Sell |
20-day SMA: | 1.21 | Sell |
50-day SMA: | 1.26 | Sell |
200-day SMA: | 1.72 | Sell |
8-day EMA: | 1.14 | Sell |
20-day EMA: | 1.19 | Sell |
50-day EMA: | 1.27 | Sell |
200-day EMA: | 1.77 | Sell |
SYRS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.36 | Sell |
20-day SMA: | 2.29 | Sell |
50-day SMA: | 2.04 | Sell |
200-day SMA: | 4.56 | Sell |
8-day EMA: | 2.15 | Sell |
20-day EMA: | 2.24 | Sell |
50-day EMA: | 2.37 | Sell |
200-day EMA: | 3.78 | Sell |
Opus Genetics Earnings Growth & IRD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.60 per share, and an increase next year of $0.04 per share.
Syros Pharmaceuticals Earnings Growth & SYRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.15 per share, and a decrease next year of $1.03 per share.
Opus Genetics Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Syros Pharmaceuticals Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |